Author: eric1436271

 BDA Partners is pleased to announce that Navis Capital (“Navis”), advised by William Blair and BDA Partners, has agreed to sell 100% of B Medical Systems (“B Med”) to Azenta, Inc (“Azenta”), a leading provider of cold-chain sample management solutions and genomics services to top pharmaceutical, biotech, academic and healthcare institutions globally. The transaction values B Med at an Enterprise Value of up to €460 million and is expected to close in October 2022. B Med is the global leader in sustainable medical cold chain solutions with a presence in over 150 countries. As the world’s single largest vaccine cold ... Read more